Drug Shortage Report for JARDIANCE
Report ID | 122787 |
Drug Identification Number | 02443937 |
Brand name | JARDIANCE |
Common or Proper name | Jardiance 30's |
Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
Market Status | MARKETED |
Active Ingredient(s) | EMPAGLIFLOZIN |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30s |
ATC code | A10BK |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-08-26 |
Actual start date | 2020-08-27 |
Estimated end date | 2020-08-31 |
Actual end date | 2020-09-11 |
Shortage status | Resolved |
Updated date | 2020-09-12 |
Company comments | Jardiance (empagliflozin) 10mg 9x10s remain available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-08-21 | English | Compare |
v2 | 2020-08-21 | French | Compare |
v3 | 2020-08-27 | English | Compare |
v4 | 2020-08-31 | English | Compare |
v5 | 2020-08-31 | French | Compare |
v6 | 2020-09-11 | English | Compare |
v7 | 2020-09-11 | English | Compare |
v8 | 2020-09-11 | French | Compare |
v9 | 2020-09-11 | English | Compare |
v10 | 2020-09-11 | French | Compare |
v11 | 2020-09-12 | English | Compare |
Showing 1 to 11 of 11